drugset / Trial / NCT02423226

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

NCT02423226 ↗

Phase 2 Completed 56 enrolled The First People's Hospital of Changzhou
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of CT guided 125I seeds implant plus systemic chemotherapy for locally recurrent rectum cancer.

Timeline

Start
2008-10
Primary completion
2014-12
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Background Irinotecan Small molecule 180 mg/m2 —
Background Leucovorin Small molecule 400 mg/m2 —
Background fluorouracil Small molecule 400 mg/m2 Intravenous
Background fluorouracil Small molecule 2.4 g Intravenous

Indications